Hayden John C, Parkin Rebecca
School of Pharmacy and Biomolecular Science, Royal College of Surgeons in Ireland, Dublin, Ireland.
Ir J Psychol Med. 2020 Sep;37(3):198-203. doi: 10.1017/ipm.2020.52. Epub 2020 May 21.
Pharmacists, like psychiatrists, have modified their practices amidst COVID-19 in order to guarantee care and support to their patients. Designated an essential frontline service, community pharmacists are facing a spectrum of challenges to surmount to ensure patient care continues. These include assisting in the prevention of infection, managing supply chains, preventing stockpiling and provision of evidence-based medical information. However, disasters like COVID-19 disproportionately affect poor and vulnerable populations, and patients with mental health conditions may be among the hardest hit. Pharmacist-level, system-level and regulatory responses have sought to minimise this impact, although there is likely to be a lasting impression on the profession, both good and bad. This article reviews the pandemic-related challenges and responses by pharmacists, as well as forming recommendation for areas of professional support and role expansion, particularly in the case of mental health.
药剂师和精神科医生一样，在新冠疫情期间调整了他们的业务，以确保为患者提供护理和支持。社区药剂师被指定为基本的一线服务人员，他们面临着一系列需要克服的挑战，以确保患者护理工作持续进行。这些挑战包括协助预防感染、管理供应链、防止囤积以及提供循证医学信息。然而，像新冠疫情这样的灾难对贫困和弱势群体的影响尤为严重，患有精神健康疾病的患者可能是受影响最严重的人群之一。尽管这可能会给该行业带来好坏参半的持久影响，但药剂师层面、系统层面和监管层面的应对措施都试图将这种影响降至最低。本文回顾了药剂师在疫情期间面临的挑战及应对措施，并就专业支持和角色扩展领域提出建议，特别是在精神健康方面。
